We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Advanced Lab-on-Chip Optical Biosensors Offer Fast, Efficient Point-of-Care COVID-19 Testing

By LabMedica International staff writers
Posted on 09 Sep 2021
Advanced lab-on-a-chip optical biosensors can enable fast accurate point of care COVID-19 diagnosis, according to researchers.

Researchers from the University of Texas at Austin (Austin, TX, USA) and Omega Optics Inc. More...
(Austin, TX, USA) investigated the opportunities and challenges in developing rapid COVID-19 sensing techniques. Without the prospect of herd immunity on the immediate horizon, speedy detection for COVID-19 remains imperative for helping to curb the pandemic. Point-of-care testing that can provide immediate results is an urgent need.

One of the most promising solutions to accurate rapid testing is using optical biosensors. When a virion is present on the surface of an optical sensor, its interaction with a light beam on the sensor affects the light's properties, causing a measurable shift in the light signal. Even with only a very small viral dosage, the system can reliably detect the coronavirus in real time. There are a number of different ways in which this interaction can be utilized and improved upon, such as integrating it with measurements of plasma oscillations or incorporating graphene into its fabrication process.

Each potential configuration uses a different mechanism to sense the virus and has its own set of advantages and drawbacks, but the primary takeaway remains the same. Even with the widespread availability of vaccines, the pandemic cannot be overcome without developing faster ways to determine infection, particularly as mutations and new variants of the virus continue to arise.

"Due to growing cases resulting from more transmissible variants around the world and the need to prevent and control cases and outbreaks when they arise, we should be utilizing rapid testing more commonly to detect and stop the spread before hitting the transmission peak," said Aref Asghari, one of the researchers. "In case of COVID-19, the viral load at the onset of infection can be low enough to not be detected by many commercially available methods. Therefore, viral detection, especially at earlier infection stage, can be very challenging."

Related Links:
University of Texas at Austin
Omega Optics Inc.



Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.